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Ehlers-Danlos VIII (EDS-VIII) is an autosomal dominant disorder characterized by severe early-onset periodontal
disease in conjunction with the features of Ehlers-Danlos syndrome (EDS). We performed a genomewide linkage
search in a large Swedish pedigree with EDS-VIII and established linkage to a 7-cM interval on chromosome 12p13,
generating a maximum multipoint LOD score of 5.17. Analysis of four further pedigrees with EDS-VIII revealed
two consistent with linkage to 12p13 and two in which linkage could be excluded, indicating that EDS-VIII is a
genetically heterogeneous disorder. Chromosome 12p13 has not previously been implicated in either EDS or perio-
dontal disease and contains no known collagen genes or collagen-processing enzymes. Mutational screening of the
microﬁbril-associated glycoprotein-2 gene, a strong candidate within the minimal interval, did not reveal any likely
pathogenic mutations.
Ehlers-Danlos syndrome (EDS) is a clinically and genet-
ically heterogeneous connective-tissue disorder character-
ized by articular hypermobility, skin hyperextensibility,
and tissue fragility (McKusick 1972; Pope and Burrows
1997). Pathogenic mutations in the genes encoding col-
lagen types I, III, and V, and the collagen-processing en-
zymes lysyl hydroxylase and procollagen N-peptidase
have been found to underlie several EDS variants (Beigh-
ton et al. 1998), which suggests that EDS is a disorder of
ﬁbrillar collagen metabolism (Byers 1995).More recently,
mutations in Tenascin-X, a large extracellular-matrixpro-
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tein of unknown function, were reported in patients with
EDS, indicating that defects outside the classic collagen
family have potential to cause EDS phenotypes (Schalk-
wijk et al. 2001).
Ehlers-Danlos VIII (EDS-VIII [MIM 130080]) is an au-
tosomal dominant condition in which severe premature
periodontal disease segregates with otherwise typical EDS
(Pope and Burrows 1997). Since the ﬁrst report in 1967,
!40 cases have been published (Barabas and Barabas
1967; Stewart et al. 1977; Linch and Acton 1979; Piette
and Douniau 1980; Lapiere and Nusgens 1981; Nelson
and King 1981; Olesen and Ernst 1987; Riedl et al. 1989;
Flachowsky et al. 1990; Hartsﬁeld and Kousseff 1990;
Biesecker et al. 1991; Hoffman et al. 1991; Bond 1993;
Cuniff and Williamson-Kruse 1995; Spranger et al. 1996;
Karrer et al. 2000). The clinical manifestations in these
patients vary, with differing degrees of skin hyperexten-
sibility, fragility, and scarring; minimal-to-moderate joint
hypermobility (usually limited to the digits); and normal
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Figure 1 Haplotypes for 17 markers from chromosome 12p13 in family A. Blackened symbol p affected with EDS-VIII. Unblackened
symbol p unaffected individual. The black bar next to marker alleles indicates that the disease-segregating haplotype is present in affected
individuals. Meiotic recombinants in individuals 3 and 18 deﬁne the minimal interval encompassing the EDS-VIII gene to the region between
markers D12S314 and D12S1695.
or slightly increased tendency to bruising onmild trauma.
Discrete, chronically inﬂamed pretibial plaques, remi-
niscent of necrobiosis lipoidica, are often present. The
underlying molecular cause of EDS-VIII is unknown. A
reduction of collagen type III was reported in a single
case (Lapiere and Nusgens 1981), but no consistent bio-
chemical or structural changes are detectable (Hartsﬁeld
and Kouseff 1990; Dyne et al. 1993).
The primary feature that discriminates EDS-VIII from
other forms of EDS is severe early-onset periodontitis.
Periodontitis is characterized by irreversible destruction
of the periodontal tissues (periodontal ligament, alveolar
bone, and connective tissue) and has many heterogeneous
causes. It is estimated to occur in 15%–20% of the adult
population and 0.5%–3% of children, depending on the
population studied (Papapanou 1996). Most forms of
periodontitis are thought to result from complex inter-
actions of pathogenic genetic variants with environmental
agents. However, speciﬁc single-gene defects can predis-
pose to some forms of periodontal disease, particularly
early-onset periodontitis, which is associated with a num-
ber of genetic syndromes, including chronic familial neu-
tropenia (MIM 162700), leucocyte adhesion deﬁciency
type II (MIM 266265), Chediak-Higashi syndrome
(MIM 214500), and Papillon-Lefevre syndrome (MIM
245000).
We ascertained a large ﬁve-generation family with
EDS-VIII from Pitea in northwestern Sweden (ﬁg. 1). This
family is referred to as “family A.” Seventy-two indi-
viduals from ﬁve generations of family A were examined
after full informed consent was obtained. Dermatologi-
cal features were assessed by one of the authors (F.M.P.),
and individuals were classiﬁed as affected using published
clinical criteria for the diagnosis of EDS (Beighton et al.
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Table 1
Two-Point LOD Scores at Chromosome-12p13 Markers in
Swedish Pedigree with EDS-VIII
MARKER
TWO-POINT LOD SCORE AT V
.00 .05 .1 .2 .3 .4
D12S352  .24 .65 .80 .61 .27
D12S100  .08 .29 .43 .32 .11
D12S1615  1.88 1.86 1.45 .89 .32
D12S1626  .84 .95 .80 .47 .13
D12S1652  3.34 3.69 2.88 1.96 .87
D12S314  .29 .47 .47 .30 .09
D12S99 2.08 1.80 1.52 .98 .49 .13
D12S356 4.04 3.66 3.26 2.40 1.50 .60
D12S374 1.76 1.52 1.28 .81 .38 .08
D12S1625 1.39 1.30 1.20 .96 .69 .37
GATA49d12 1.39 1.25 1.09 .76 .44 .17
GATA151h0 2.76 2.53 2.27 1.66 .99 .38
D12S336 .711 .60 .49 .28 .12 .02
D12S1695  1.10 1.12 .85 .45 .13
GATA167a0  1.40 1.51 1.33 .93 .43
D12S89 1.99 1.85 1.69 1.31 .87 .36
D12S364  .64 .95 0.94 .62 .21
1998). Independently, dental features were examined by
another author (B.F.), and standard dental criteria were
used to diagnose early-onset periodontitis. The affection
status as determined by dermatological and dental cri-
teria were entirely congruent in all individuals.
The predominant dental featureswere prematureperio-
dontal inﬂammation and gingival recession, usually de-
tectable in childhood, with rapid progression throughout
adolescence and early adulthood. In general, complete
loss of adult dentition occurred, typically, in individuals
born prior to 1950, by the end of the third decade.
Dental X-rays of selected family members showed pro-
gressive loss of periodontal supporting tissue and loss of
bony tissue.
Affected individuals showed typical features of EDS,
with generalized joint laxity (Beighton scores 5/9–9/9),
thin atrophic skin, (especially over the dorsum of the
hands and feet), and circumscribed hemosiderotic preti-
bial plaques, which could be thickened or atrophic. Af-
fected individuals were tall, with spans wider than their
heights.
Collagen protein analysis and transmission electronmi-
croscopy showed no evidence of collagen III deﬁciency.
However, subtle irregularities in the pattern of dermal
collagen ﬁbrils, with an abnormally mixed pattern of
larger and smaller ﬁbrils, were observed (data not shown).
A genomewide linkage search was performed, using
11 affected individuals from family A. Four hundred
microsatellite markers spaced at ∼10-cM intervals from
ABI PRISM linkage-mapping set version 2 (Applied
Biosystems) were PCR ampliﬁed, by use of standard pro-
tocols. Ampliﬁed markers were electrophoresed on an
ABI 3770 DNA capillary sequencer and were analyzed
with GENESCAN and GENOTYPER software (Applied
Biosystems).
EDS-VIII was modeled as an autosomal dominant trait
that is fully penetrant by age 15 years. Unaffected in-
dividuals under age 15 years were coded as “unknown.”
A disease allele frequency of .001 and equal recombi-
nation fractions in males and females were assumed.Two-
point LOD scores were calculated by use of the MLINK
program of LINKAGE (Lathrop et al. 1984), and mul-
tipoint LOD scores (four markers and the disease) were
generated by use of VITESSE (O’Connell and Weeks
1995). Marker allele frequencies were estimated from
individuals in the pedigree.
In the initial linkage search, marker D12S99 generated
the highest two-point LOD score, and positive LOD
scores at consecutive markers occurred only at D12S99
and D12S336 on chromosome 12p13. To conﬁrm and
reﬁne the location of the EDS-VIII predisposition gene,
15 additional markers spanning a 30-cM interval on chro-
mosome 12p were analyzed. Samples from ﬁve unaffected
relatives and three spouses were included in these analy-
ses (ﬁg. 1). The order and distance between the markers
were obtained from the Marshﬁeld Genetic Database
and are presented telomeric to centromeric, as follows:
D12S352-3.3 cM-D12S100-1.3 cM-D12S1615-2.5 cM-
D12S1626-0.5 cM-D12S1652-3.8 cM-D12S314-1.2 cM-
D12S99-1.6 cM-D12S356-0 cM-D12S374-2.2 cM-
D12S1625-1.3 cM-GATA49d12-0 cM-GATA151h0-1.3
cM-D12S336-0.6 cM-D12S1695-0.7 cM-GATA167a0-
2.9 cM-D12S89-6.2 cM-D12S364. A haplotype of
marker alleles segregates with the disease in all affected
patients and is not present in any of the unaffected in-
dividuals (ﬁg. 1). Critical meiotic recombinants in ID-3
(telomeric) and ID-18 (centromeric) place the EDS-VIII
predisposition gene in a 7-cM region ﬂanked by
D12S314 and D12S1695 (ﬁg. 1). The maximum two-
point LOD score was 4.04 at D12S356 (table 1). The
maximum multipoint LOD score was 5.17 close to
D12S356 (ﬁg. 2).
We analyzed a further four pedigrees with EDS-VIII
(families B, C, D, and E) for linkage to chromosome
12p13 (ﬁg. 3). Affected individuals from all four pedigrees
were examined by one of the authors (F.M.P.) and were
considered typical of EDS-VIII. Eight chromosome-12p13
microsatellite markers spanning the critical EDS-VIII in-
terval were analyzed in each pedigree. In families D and
E, the affected individuals do not share a chromosome-
12p13 haplotype, and some unaffected individuals carry
the same chromosome-12p13 haplotype as affected in-
dividuals (ﬁg. 3). This excludes the EDS-VIII gene we
have identiﬁed as the causative gene in these two families
and demonstrates that EDS-VIII is a genetically hetero-
geneous disorder. Family B contains six affected individ-
uals in three generations. DNA was available from four
affected individuals, and all share a chromosome-12p13
Reports 201
Figure 2 Multipoint LOD score at chromosome 12p13 in family A
haplotype that generates a multipoint LOD score of 0.42
at D12S356 (ﬁg. 3). Similarly, family C contains three
affected individuals and is also consistent with linkage
to chromosome 12p13 generating amultipoint LODscore
of 0.28 at D12S356. Thus, the occurrence of EDS-VIII
in these two families may well be due to the chromosome
12p13 EDS-VIII gene, but the families are too small to
give unequivocal evidence in favor of linkage in the con-
text of known genetic heterogeneity.
Localization of an EDS-VIII gene to chromosome
12p13 has important implications. What is most impor-
tant is that it provides the ﬁrst clear evidence for the
existence of EDS-VIII as a separate clinical entity. This
has long been a point of contention, with some believing
EDS-VIII to be a phenotypic variant of EDS-IV (MIM
130050), which is due to mutations in theCOL3A1 gene
on chromosome 2q31-32 (Hartsﬁeld and Kouseff 1990;
Dyne et al. 1993). Our data now provide molecular evi-
dence that discriminates EDS-VIII from EDS-IV. This
distinction has clinical implications for patients diag-
nosed with EDS-VIII, as it suggests they are unlikely to
be at the same risk of the severe vascular complications
seen in EDS-IV (Pepin et al. 2000).
Neither of the families unlinked to chromosome 12p13
has clinical features characteristic of EDS-IV. Further-
more, collagen protein analysis in family E demonstrated
normal collagen III production and excretion, which pre-
cludes EDS-IV. Collagen analysis was not performed in
family D. However, whenmicrosatellitemarkersD2S103,
D2S118, and D2S389, which closely ﬂank COL3A1,
were analyzed, they revealed that the affected sons have
inherited opposite chromosome-2 haplotypes in this re-
gion from their affected father (data not shown). These
data strongly suggest that COL3A1 mutations are not
responsible for the EDS-VIII phenotype seen families D
and E. In turn, this suggests that at least one further,
currently unknown, EDS-VIII predisposition gene is likely
to exist.
No other EDS-susceptibility gene has been mapped to
chromosome 12p13, which indicates that a previously
unrecognized gene can predispose to the Ehlers-Danlos
phenotype. The genomic sequence of the critical interval
is incomplete, but scrutiny of the UCSCHumanGenome
Project Working Draft indicates that the minimal inter-
val is 4.6 Mb and contains 44 known genes and 16
anonymous and/or predicted genes. Within the minimal
interval, there are no known collagen genes or collagen-
modifying enzymes. The most promising candidate gene
is microﬁbril-associated glycoprotein-2 (MAGP2) (Gib-
son et al. 1996). MAGP1 and MAGP2 are small, struc-
turally related glycoproteins that speciﬁcally associate
with ﬁbrillin-containing microﬁbrils. Fibrillin-containing
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Figure 3 Haplotypes for eight chromosome-12p13 markers in four additional pedigrees with EDS-VIII (families B, C, D, and E). The
segregating 12p13 haplotypes in affected individuals are depicted by black and hatched bars next to marker alleles. Inferred haplotypes are in
parentheses.
microﬁbrils are important structural components of the
extracellular matrix of most connective tissues.Morpho-
logically identical microﬁbrils are found in association
with elastin in tissues such as the aorta and elastic liga-
ments and as elastin-free bundles in other tissues, in-
cluding the periodontal ligament and skin. MAGP1 and
MAGP2 each contain a characteristic cysteine-rich core
motif that is thought to be involved, in interactions of
MAGPs, with other components of the microﬁbril. In
addition, the N-terminal region of MAGP2 contains an
RGD motif and interacts with a wide range of cell types
in an RGD-dependent manner via aVb3 integrin (Gibson
et al. 1999). Of interest, Tenascin-X also contains an
RGD sequence and mediates interactions via the same
integrin subunit combination (Elefteriou et al. 1999).
We screened genomic DNA from affected and unaf-
fected individuals from families A, B, and C for muta-
tions in MAGP2, by use of conformation sensitive gel
electrophoresis (Ganguly et al. 1993). Primers were de-
signed to amplify the 10 exons and intron-exon bound-
aries of MAGP2, by use of primer3 software (table 2).
No likely pathogenic alterations were detected, and no
sequence variants segregating with the EDS-VIII pheno-
type were identiﬁed in any family (data not shown). This
suggests that MAGP2 is not an EDS-VIII–predisposition
gene, although it is possible that we have failed to detect
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Table 2
MAGP2 Mutation Screening Primers and Size of PCR Product
Exon Forward Primer Reverse Primer
Size
(bp)
1 gcaactgcaaattcccatct cattccctctgtctctttaggg 284
2 tgcctctgagcatcacattc tcttcgacctcattccatcc 193
3 ccatttctccatgattttctga tggcagcgatagataagcag 228
4 tggcagggagacagagaatc cctccaacccttctgaagtc 198
5 tccccttatcctgctttcct gggcaacagaatgagactcc 259
6 gccttgtgtttgcaatttga tcagcagctgcacactatcc 186
7 gcactccaagcaggtcctaa gtgccaagtaccctccaaag 212
8 cccaattccttcaatccttc gcaattccatagtgggtgct 251
9 atcccagacccaggtgagtt gcctgaagccctcctctagt 259
10 tctgcattctcttcccatga cctccttcctctcacccata 202
deleterious MAGP2 alterations, either owing to lack of
sensitivity of the screening technique or because they re-
sult in alterations that are not detectable by our methods,
such as genomic rearrangements or regulatory mutations.
Mapping of the EDS-VIII gene also has implications
for other forms of periodontal disease. Our data demon-
strate that a gene predisposing to early-onset periodontal
disease is located at chromosome 12p13. No genes within
this chromosomal interval have previously been impli-
cated in periodontal disease. Because the cutaneous fea-
tures in pedigrees with EDS-VIII can be variable and
sometimes subtle, it would be instructive to examine
pedigrees with familial periodontal disease for linkage
to chromosome 12p13. Isolation of the EDS-VIII gene
will allow more focused investigations of its functions
and is likely to greatly further our understanding of the
molecular mechanisms that lead to both EDS and perio-
dontal disease.
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